Maintenance therapy after 1st line chemotherapy for advanced urothelial carcinoma, 21 Apr. 2023, 20 Apr. 2023, 23 Apr. 2023, Poster presentation, Japan, False
Multicenter real-word date of maintenance therapy after first-line chemotherapy for advanced urotheline carcinoma:YUSHIMA study, Keita Izumi, Hajime Tanaka, Masataka Yano, Ryoji Takazawa, Akira Noro, Tetsuo Tsukamoto, Yonese Junji, Testuo Okuno, Yasuyuki Sakai, Yukio Kageyama, Fumitaka Koga, Kazutaka Saito, Yasuhisa Fujii., 25 Apr. 2024, Japan
Prognostic impact of bone metastasis in up front androgen receptor-axis-targeted therapy for metastatic castration-sensitinve prostate vancer prostate cancer, Akinori Nakayama, Erika Ilezoe, Minoru Inoue, Hiroki Tsujioka, Asumi nirazuka, ki
Testicular sperm retrieval in hemodialysis patients with sexual dysfunction, Akiyoshi Oosaka, Toshiyuki Iwahata, Erika Ikezoe, Minoru Inoue, Hiroki Tsujioka, Kintaro Hasegawa, Nirazuka Asumi, Miho Sugie, Yuka Yasuda, Keita Izumi, Akinori Nakayama, Hiroshi Okada, Kazutaka Saito., 26 Apr. 2024
Algorithm for neoadjuvant chemotherapy in nonmetastatic upper tract urothelial carcinoma, Asumi Nirazuka, Keita Izumi, Erika Ikezoe, Minoru Inoue, Hiroki Tsujioka, Kinotaro Hasegawa, Akiyoshi Oosaka, Yuka Yasuda, Akinori Nakayama, Kiyoshi Setoguchi, Kazutaka Saito., 25 Apr. 2024
Histologic-based tumor microenvironment characteristics of serum inflamed tumor in clear cell renal cell carcinoma, Minoru Inoue, Keita Izumi, Akinori Nakayama, Chisato Ohe, Shinichi Ban, Kazutaka Saito., 25 Apr. 2024
Clinical Significance of Peritoneal Closure in Transperitoneal Robotic-Assisted Radical Prostatectomy, Keita Izumi, Yusuke Hara, Erika Ikezoe, Hiroki Tsujioka, Kintaro Hasegawa, Asumi Nirazuka, Akiyoshi Oosaka, Toshiyuki Iwahata, Akinori Nakayama, Kiyoshi Setoguchi, Kazutaka Saito, The 112th Annual Meeting of the Japanese Urological Associarion, 19 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Oral presentation, Japan, False
Timing of radiographic progression on prostate-specific antigen kinetics in metastatic castration-sensitive prostate cancer patients received upfront therapy, Erika Ikezoe, Akinori Nakayama, Yusuke Hara, Hiroki Tsujioka, Asumi Nirazuka, Kintaro Hasegawa, Keita Izumi, Kiyoshi Setoguchi, Kazutaka Saito, The 112th Annual Meeting of the japanese Urological Association, 17 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Oral presentation, Japan, False
Clinical significance of preoperarive CRP in intermediate-high risk clear cell renal cell carcinoma: Can a good prognosis group be selected?, Asumi Nirazuka, Akinori Nakayama, Erika Ikezoe, Minoru Inoue, Keita Izumi, Kiyoshi Setoguchi, Chisato Ohe, Shinichi Ban, Kazutaka Saito, The 112th Annual Meeting of the Japanese Urological Associarion, 17 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Japan, False
Evaluation of prognostic Factor for sperm DNA fragmentation, Akiyoshi Oosaka, Toshiyuki Iwahata,Yusuke Hara, Erika Ikezoe, Hiroki Tsujioka, Asumi Nirazuka, Kintaro Hasegawa, Miho Sugie, Keita Izumi, Akinori Nakayama, Kiyoshi Setoguchi, Hiroshi Okada, Kazutaka Saito, The 112th Annual Meeting of the Japanese Urological Associarion, 18 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Japan, False
Impact of C-reactive protein kinetics on the prognosis of the patient with metastatic urotherial carcinoma treated with enfortumab vedotin, Hiroki Tsujioka, Keita Izumi, Yusuke Hara, Erika Ikezoe, Kintaro Hasegawa, Asumi Nirazuka, Akiyoshi Oosaka, Toshiuki Iwahata, Akinori Nakayama, Kiyoshi Setoguchi, Kazutaka Saito, The 112th Annual Meeting of the Japanese Urological Associarion, 18 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Poster presentation, Japan
Initial Experience with triplent therapy for metastatic castration senstive prostate cancer, Yusuke Hata, Akiyoshi Nakayama, Erika Ikezoe, Minoru inoue, Hiroki Tsujioka, Asumi Nirazuka, Kintaro Hasehgawa, Akiyoshi Oosaka, Keita Izumi, Toshiuki Iwahata, Kiyoshi Setoguchi, Kazutaka Saito, The 112th Annual Meeting of the Japanese Urological Associarion, 18 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Poster presentation, Japan, False